| Ms Sharon Yan Liu, DO | |
|
1647 Woodbrooke Dr, Salisbury, MD 21804-8502 | |
| (410) 546-2424 | |
| (410) 742-6633 |
| Full Name | Ms Sharon Yan Liu |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 25 Years |
| Location | 1647 Woodbrooke Dr, Salisbury, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972537496 | NPI | - | NPPES |
| 119591300 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | H0061208 (Maryland) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Peninsula Regional Medical Center | Salisbury, MD | Hospital |
| Beebe Medical Center | Lewes, DE | Hospital |
| Nanticoke Memorial Hospital | Seaford, DE | Hospital |
| Umd Shore Medical Center At Easton | Easton, MD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Three Lower Counties Community Services Inc. | 3678484300 | 67 |
News Archive
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
Toronto, Canada's largest city, has reported 94,943 cases of COVID-19 and 2,614 related deaths so far during this pandemic. Toronto has a population of over 2.7 million people, of whom 51.5% self-identify as a visible minority. Shelter-in-place orders and shut down of non-essential businesses are the primary non-pharmaceutical interactions deployed as part of Toronto's COVID-19 response.
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
› Verified 5 days ago
| Entity Name | Three Lower Counties Community Services Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154354744 PECOS PAC ID: 3678484300 Enrollment ID: O20040324000093 |
News Archive
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
Toronto, Canada's largest city, has reported 94,943 cases of COVID-19 and 2,614 related deaths so far during this pandemic. Toronto has a population of over 2.7 million people, of whom 51.5% self-identify as a visible minority. Shelter-in-place orders and shut down of non-essential businesses are the primary non-pharmaceutical interactions deployed as part of Toronto's COVID-19 response.
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
› Verified 5 days ago
| Entity Name | Luminis Health Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073580205 PECOS PAC ID: 2860447315 Enrollment ID: O20050317000146 |
News Archive
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
Toronto, Canada's largest city, has reported 94,943 cases of COVID-19 and 2,614 related deaths so far during this pandemic. Toronto has a population of over 2.7 million people, of whom 51.5% self-identify as a visible minority. Shelter-in-place orders and shut down of non-essential businesses are the primary non-pharmaceutical interactions deployed as part of Toronto's COVID-19 response.
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Sharon Yan Liu, DO Po Box 1978, Salisbury, MD 21802-1978 Ph: (410) 749-1015 | Ms Sharon Yan Liu, DO 1647 Woodbrooke Dr, Salisbury, MD 21804-8502 Ph: (410) 546-2424 |
News Archive
Altair Therapeutics, Inc., a privately-held, biopharmaceutical company developing novel therapeutics for respiratory diseases, today announced the commencement of its IL-4 receptor alpha inhibitor bronchoprovocation trial. Study AIR645-CS2 is a phase 2, multi-center, randomized, double-blind, placebo-controlled study to assess the safety, tolerability, and efficacy of inhaled AIR645 in suppressing the asthmatic response in subjects with mild asthma. Results are expected in the third quarter of 2010.
Emerging Healthcare Solutions, Inc. announced today that the company has successfully completed the due diligence and review requirements under their recent option agreement with ThromboVision, a company that has licensed the patent on the new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.
Toronto, Canada's largest city, has reported 94,943 cases of COVID-19 and 2,614 related deaths so far during this pandemic. Toronto has a population of over 2.7 million people, of whom 51.5% self-identify as a visible minority. Shelter-in-place orders and shut down of non-essential businesses are the primary non-pharmaceutical interactions deployed as part of Toronto's COVID-19 response.
Exemestane, a drug used in the prevention of breast cancer in postmenopausal women, has a negative effect on bone density and structure in these women, despite calcium and vitamin D supplements.
› Verified 5 days ago
Mr. Ho K Cho, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 560 Riverside Dr, A 203, Salisbury, MD 21801 Phone: 410-749-4455 Fax: 410-749-3663 | |
Dr. Glen H. Silas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 600 Glen Ave Ste 104, Salisbury, MD 21804 Phone: 410-543-9111 Fax: 410-543-9115 | |
Dr. Constantine G Lambrou, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 204 Newton Street, Salisbury, MD 21801 Phone: 410-742-2500 Fax: 410-546-0621 | |
Dr. Kelli Renee Luttrell, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1647 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-546-2424 Fax: 410-742-6633 | |
Dr. Joseph Jackson Welch Iii, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 106 Pine Bluff Rd, Suite 13, Salisbury, MD 21801 Phone: 410-546-5255 | |
Dr. Bryon Nicholas Jacoby, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1647 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-546-2424 Fax: 410-742-6633 | |
Dr. Caitlin Lindsley Robinson, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1647 Woodbrooke Dr, Salisbury, MD 21804 Phone: 410-546-2424 Fax: 410-742-6633 |